Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

1.

Gene expression variation in Down's syndrome mice allows prioritization of candidate genes.

Sultan M, Piccini I, Balzereit D, Herwig R, Saran NG, Lehrach H, Reeves RH, Yaspo ML.

Genome Biol. 2007;8(5):R91.

PMID:
17531092
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo ML.

Genome Res. 2004 Jul;14(7):1258-67.

PMID:
15231742
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Developmental instability of the cerebellum and its relevance to Down syndrome.

Shapiro BL.

J Neural Transm Suppl. 2001;(61):11-34. Review.

PMID:
11771737
[PubMed - indexed for MEDLINE]
4.

Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.

Amano K, Sago H, Uchikawa C, Suzuki T, Kotliarova SE, Nukina N, Epstein CJ, Yamakawa K.

Hum Mol Genet. 2004 Jul 1;13(13):1333-40. Epub 2004 May 11.

PMID:
15138197
[PubMed - indexed for MEDLINE]
Free Article
5.

Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.

Galdzicki Z, Siarey RJ.

Genes Brain Behav. 2003 Jun;2(3):167-78. Review.

PMID:
12931790
[PubMed - indexed for MEDLINE]
6.

Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.

Rachidi M, Lopes C.

Neurosci Res. 2007 Dec;59(4):349-69. Epub 2007 Aug 15. Review.

PMID:
17897742
[PubMed - indexed for MEDLINE]
7.

Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.

Rachidi M, Lopes C.

Eur J Paediatr Neurol. 2008 May;12(3):168-82. Epub 2007 Oct 22. Review.

PMID:
17933568
[PubMed - indexed for MEDLINE]
8.

Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.

Olson LE, Roper RJ, Sengstaken CL, Peterson EA, Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH.

Hum Mol Genet. 2007 Apr 1;16(7):774-82. Epub 2007 Mar 5.

PMID:
17339268
[PubMed - indexed for MEDLINE]
Free Article
9.

Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH.

Hum Mol Genet. 2000 Jan 22;9(2):195-202.

PMID:
10607830
[PubMed - indexed for MEDLINE]
Free Article
10.

Global disruption of the cerebellar transcriptome in a Down syndrome mouse model.

Saran NG, Pletcher MT, Natale JE, Cheng Y, Reeves RH.

Hum Mol Genet. 2003 Aug 15;12(16):2013-9.

PMID:
12913072
[PubMed - indexed for MEDLINE]
Free Article
11.

Gene expression variation increase in trisomy 21 tissues.

Chou CY, Liu LY, Chen CY, Tsai CH, Hwa HL, Chang LY, Lin YS, Hsieh FJ.

Mamm Genome. 2008 Jun;19(6):398-405. doi: 10.1007/s00335-008-9121-1. Epub 2008 Jul 2.

PMID:
18594911
[PubMed - indexed for MEDLINE]
12.

Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome.

Holtzman DM, Bayney RM, Li YW, Khosrovi H, Berger CN, Epstein CJ, Mobley WC.

EMBO J. 1992 Feb;11(2):619-27.

PMID:
1371464
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.

Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH.

Dev Dyn. 2004 Jul;230(3):581-9.

PMID:
15188443
[PubMed - indexed for MEDLINE]
Free Article
14.

Down syndrome gene dosage imbalance on cerebellum development.

Moldrich RX, Dauphinot L, Laffaire J, Rossier J, Potier MC.

Prog Neurobiol. 2007 Jun;82(2):87-94. Epub 2007 Feb 23. Review.

PMID:
17408845
[PubMed - indexed for MEDLINE]
15.

Cell damage by excess CuZnSOD and Down's syndrome.

Groner Y, Elroy-Stein O, Avraham KB, Schickler M, Knobler H, Minc-Golomb D, Bar-Peled O, Yarom R, Rotshenker S.

Biomed Pharmacother. 1994;48(5-6):231-40.

PMID:
7999984
[PubMed - indexed for MEDLINE]
17.

Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.

Potier MC, Rivals I, Mercier G, Ettwiller L, Moldrich RX, Laffaire J, Personnaz L, Rossier J, Dauphinot L.

J Neurochem. 2006 Apr;97 Suppl 1:104-9.

PMID:
16635258
[PubMed - indexed for MEDLINE]
18.

Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.

Blazek JD, Billingsley CN, Newbauer A, Roper RJ.

Dev Dyn. 2010 Jun;239(6):1645-53. doi: 10.1002/dvdy.22295.

PMID:
20503361
[PubMed - indexed for MEDLINE]
Free Article
19.

Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.

Kazuki Y, Kimura M, Nishigaki R, Kai Y, Abe S, Okita C, Shirayoshi Y, Schulz TC, Tomizuka K, Hanaoka K, Inoue T, Oshimura M.

Biochem Biophys Res Commun. 2004 Apr 30;317(2):491-9.

PMID:
15063784
[PubMed - indexed for MEDLINE]
20.

Molecular neuropathology of transgenic mouse models of Down syndrome.

Cairns NJ.

J Neural Transm Suppl. 2001;(61):289-301. Review.

PMID:
11771752
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk